Cardiovacular - Biobanking.com

Home Tags Cardiovacular

IPS HEART Aims To Use Induced Pluripotent Stem Cells To Treat Heart Attack

Industry News David Orchard-Webb, PhD

IPS HEART is a privately-held biopharmaceutical company, founded in 2014, dedicated to addressing heart attack, heart failure and Duchenne cardiomyopathy via next generation cellular therapy. IPS HEART was the first company to exclusively focus on induced pluripotent stem cells...

⭐ Recently Featured

Biobanking: A Silent Hero in the Fight Against Climate Change

Expert Contributions

Biobanking: A Silent Hero in the Fight Against Climate Change

Unlocking the Future Evolution and Impact of Biobanking Networks in the Next Decade

Unlocking the Future: Evolution and Impact of Biobanking Networks in the Next Decade

Expert Contributions

Unlocking the Potential of Multiomics in Biobanking: An Interview with Dr. Aarno Palotie, Scientific Director of FinnGen

Unlocking the Potential of Multiomics in Biobanking: An Interview with Dr. Aarno Palotie, Scientific Director at FinnGen

DNA/RNA Banking

Leverage a Biorepository Management System for Decarbonization in Biobanking

Driving Decarbonization in Biobanking for Environmental Sustainability with a Biorepository Management System

Data & Informatics

Automated Biobanking: Advantages, Benefits and Future Directions

Automated Biobanking: Advantages, Benefits and Future Directions

🔥 Popular Posts

Biobank Profiles

10 Largest Biobanks in the World

Biobanking LIMS Softwares

10 Top Laboratory Information Management Systems (LIMS Softwares) for Biobanking

Data & Informatics

Biobank Facilities

Biobank versus Biorepository: What’s in a Name?

Insights & Opinions

Biobanks can comply with regulatory requirements by following ISBER Best Practices.

Biobanking Science: ISBER Best Practices for Biobanks

Biopreservation Science

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

X